Mukesh Ambani Now World's Fifth Richest, Just After Mark Zuckerberg
- Reliance Industries' shares surged to an all-time high of Rs 2,010 on Wednesday, taking the group's market capitalisation to Rs 12.70 lakh crore.
- That helped Mr Ambani-led Reliance Industries retain its position as India's most valuable company.
- Mr Ambani's net worth increased by $3.2 billion on Wednesday, according to Forbes, marking a jump of 4.49 per cent.Â
- According to the Forbes list, Amazon founder and CEO Jeff Bezos is at the top position in the list, with a net worth of $185.8 billion.
- Mr Bezos is followed by Microsoft co-founder Bill Gates ($113.1 billion) at the second position. At the third spot is luxury group LVMH Moet Hennessy Louis Vuitton's chief Bernard Arnault and his family, with a net worth of $112 billion. He is followed by Mr Zuckerberg, who is at the fourth position in the Forbes list.
- Reliance Industries is now "in its golden decade", Mr Ambani said last month, as his group became net debt-free way ahead of its target of March 2021.
- "I have fulfilled my promise to the shareholders by making Reliance net debt-free much before our original schedule of 31st March 2021," he said, as his group reached the milestone.
- Reliance sold a nearly 33 per cent stake in its digital services arm, Jio Platforms, to prominent investors including internet giants Facebook and Google.
- The latest investor in Jio Platforms - which houses telecom major Reliance Jio Infocomm - is Google, which has committed a capital infusion of Rs 33,737 crore for a 7.7 per cent stake.
- The sale of stakes in Jio along with its partnership with global oil major BP and a rights issue worth Rs 53,000 crore helped Reliance Industries become net debt-free.
-
Getting To Work Costs Women More | The Reason Why
It is not just about women paying more than men. It is about women paying much more in cities than in villages.
-
AI Bias In Investing Cannot Be Eliminated, But It Can Be Governed
Framing is a particularly important example as identical financial information presented in terms of gains rather than losses can lead an LLM to reach a different assessment.
-
Joining The Dots | Dark Skies, Steady Diya: Why Hope Holds This Diwali
With war, a weak rupee and foreign outflows weighing on sentiment, policymakers at the NDTV World Summit and market veterans at NDTV Profit Ignite: Diwali Edition offered the same advice: stay invested and filter out the noise.
-
The Curious Case of Equitas Small Finance Bank And A CEO Who Quit For Stock
PN Vasudevan believes persistent investor concerns over a perceived conflict of interest had become a governance overhang on Equitas Small Finance Bank's stock, even as the lender improved profitability and asset quality.
-
Talking Points This Week: AI Cash Burn, A Tiger Comeback And An India That Still Finds Its Own Path
India is not immune to higher oil or tighter global liquidity, yet its earnings base is broader, its domestic policy levers are still available.
-
Foreign Investors Own Half Of HDFC Bank and ICICI Bank. An LTCG Cut Could Matter Most Here
Foreign portfolio investors have US$115 billion parked in HDFC Bank, ICICI Bank. If the government cuts long-term capital gains tax, Jefferies says returning foreign money could land here first.
-
'Never Seen This Level Of Negativity': Sandeep Tandon Says The Next Rally May Be Closer Than You Think
Veteran investor Sandeep Tandon says foreign selling is easing, large-caps are due a comeback and mid-caps are crowded, while he turns positive on gold, power and pharma this Diwali.
-
Indians Stay With Family, Not In Hotels | The Reason Why
India still lacks enough clean, reliable and affordable hotels for budget-conscious travellers.
-
The Economic Imperative: Analysing The Material Driving Force Behind India-Canada Strategic Reset
This economic complementarity is further reinforced by deep institutional investment ties and talent mobility, which form the bedrock of the bilateral framework.
-
Medicine Pricing: Where Must Profit Stop?
India must confront excessive margins, hidden incentives and regulatory gaps that threaten the integrity of medicine.
